Skip to main content
Clinical Trials/DRKS00005261
DRKS00005261
Recruiting
未知

A multicenter randomized controlled trial to investigate the treatment outcome of PHILOS Screw Augmentation compared to PHILOS without augmentation in older adult patients with proximal humerus fractures - Philos+

AO Documentation and Publishing Foundation0 sites144 target enrollmentJanuary 15, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Proximal humerus fractures
Sponsor
AO Documentation and Publishing Foundation
Enrollment
144
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 15, 2014
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
AO Documentation and Publishing Foundation

Eligibility Criteria

Inclusion Criteria

  • \= 65 years
  • Low energy trauma (eg, fall from standing height)
  • Radiologically confirmed closed fracture (\= 10 days) of the proximal humerus
  • Any displaced or unstable 3\- or 4\-part fracture of the proximal humerus (ie, segment displacement \>0\.5 cm or angulated \> 45°) except isolated displaced fractures of the greater or lesser tuberosity
  • Primary fracture treatment with a PHILOS plate
  • Ability to understand the content of the patient information / informed consent form
  • Willingness and ability to participate in the clinical investigation including imaging and follow\-up procedures (FUs)
  • Signed informed consent

Exclusion Criteria

  • Bilateral or previous proximal humerus fractures on either side
  • Splitting fracture of the humeral head or humeral head impression fracture
  • Cuff\-arthropathy of the contra\- or ipsilateral proximal humerus
  • Associated nerve or vessel injury
  • Any known clotting disorders, severe cardiac and/or pulmonary insufficiency
  • Known hypersensitivity or allergy to any of the components of Traumacem V\+ Cement Kit
  • Any severe systemic disease: class 4 \- 6 of the American Society of Anesthesiologists (ASA) physical status classification
  • Any not medically managed severe systemic disease: class 3 of the ASA physical status classification
  • Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Outcomes

Primary Outcomes

Not specified

Similar Trials